- Acalabrutinib: Uses, Dosage, Side Effects, Warnings - Drugs. com
What is acalabrutinib? Acalabrutinib (Calquence) is a targeted cancer treatment used for chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL), in certain patients It helps slow the progression of cancer and helps extend patients' lives
- Acalabrutinib - Wikipedia
Acalabrutinib, sold under the brand name Calquence, is an anti-cancer medication used to treat various types of non-Hodgkin lymphoma, including mantle cell lymphoma and chronic lymphocytic leukemia small lymphocytic lymphoma [7]
- Acalabrutinib (oral route) - Side effects dosage - Mayo Clinic
Acalabrutinib is used in combination with bendamustine and rituximab to treat mantle cell lymphoma (MCL) in patients who have not received other medicines and who cannot receive autologous hematopoietic stem cell transplant (stem cell transplant that uses your own stem cells)
- Treatment for CLL SLL and R R MCL | CALQUENCE® (acalabrutinib)
Learn about CALQUENCE® (acalabrutinib), a treatment option for mantle cell lymphoma (MCL), and chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
- Acalabrutinib Capsules: Uses Side Effects - Cleveland Clinic
Acalabrutinib is a medication that stops cancer cells from growing to treat mantle cell lymphoma, chronic lymphocytic leukemia and small lymphocytic lymphoma This medication comes in a capsule form that you can take by mouth with a glass of water as directed
- Calquence (acalabrutinib) - Uses, Side Effects, and More
Find patient medical information for Calquence (acalabrutinib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- label - Food and Drug Administration
Acalabrutinib is a small-molecule inhibitor of BTK Acalabrutinib and its active metabolite, ACP-5862, form a covalent bond with a cysteine residue in the BTK active site, leading to inhibition
- Acalabrutinib (Calquence®) - Macmillan Cancer Support
Acalabrutinib (Calquence®) is a cancer drug It is used to treat a type of blood cancer called chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
|